TNBI
Tanke Biosciences Corp
Key Financials
Gross Profit
$9.9M
↑ 13.4%
Operating Income
$4.5M
↑ 160.6%
Net Income
$-210247
↑ 93.3%
Revenue
$28.6M
↑ 19.8%
EPS (Diluted)
$-0.24
↓ 170.6%
Total Liabilities
$12.9M
↑ 43.1%
Total Assets
$28.8M
↑ 15.9%
Cash & Equivalents
$6.2M
↓ 19.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| RW | 3/19/2024 | View on SEC |
| RW | 3/15/2024 | View on SEC |
| 10-12G | 2/8/2024 | View on SEC |
| 15-12G | 12/31/2013 | View on SEC |
| 8-K | 12/26/2013 | View on SEC |
| 8-K | 11/22/2013 | View on SEC |
| 10-Q | 11/14/2013 | View on SEC |
| 8-K | 10/4/2013 | View on SEC |
| 8-K | 8/29/2013 | View on SEC |
| 10-Q | 8/14/2013 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | TNBI |
| Company Name | Tanke Biosciences Corp |
| CIK | 1452011 |
| Sector | Grain Mill Products |
| SIC Code | 2040 |
| SIC Description | Grain Mill Products |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NV |
| Phone | 86-20-38859025 |